Literature DB >> 33607815

The value of caudate lobectomy in hilar cholangiocarcinoma treatment: A meta-analysis.

Ming Yang1, Wei Wei Li1, Jian Hua Chen2, Miao Hang Cui1, Jin Long Liu1.   

Abstract

PURPOSE: To discuss the value of caudate lobectomy in hilar cholangiocarcinoma (HCCA) treatment.
METHODS: A systematic review was performed in PubMed, MEDLINE database, EMBASE, and Cochrane Library for trials comparing combined caudate lobectomy with controls from January 1, 1990 to December 2, 2020. The outcomes were postoperative radical cure information, survival condition, morbidity, and mortality. RESULT: Ten studies were included. No difference was observed in the morbidity (odd ratio (OR) 0.93, 95% confidence interval (CI) 0.65-1.33) and mortality (OR 1.16, 95% CI 0.55-2.42) between the combined caudate lobectomy and control groups. Hepatectomy combined with caudate lobectomy was associated with higher incidence of radical resection (OR 3.88, 95% CI 2.18-6.90) and longer survival (hazard ratio 0.45, 95% CI 0.38-0.55).
CONCLUSION: Combining caudate lobectomy can significantly increase the incidence of radical resection of HCCA and the postoperative survival time. The morbidity and mortality were not increased after the operation. Thus, caudate lobectomy should be included when performing partial hepatectomy for HCCA.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33607815      PMCID: PMC7899860          DOI: 10.1097/MD.0000000000024727

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  43 in total

1.  Surgery for hilar cholangiocarcinoma: an Italian experience.

Authors:  G M Gazzaniga; M Filauro; C Bagarolo; L Mori
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

2.  The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

Authors:  Mechteld C de Jong; Hugo Marques; Bryan M Clary; Todd W Bauer; J Wallis Marsh; Dario Ribero; Pietro Majno; Ioannis Hatzaras; Dustin M Walters; Andrew S Barbas; Raquel Mega; Richard D Schulick; Michael A Choti; David A Geller; Eduardo Barroso; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

3.  Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?

Authors:  Masaru Miyazaki; Atsushi Kato; Hiroshi Ito; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Hiroyuki Yoshidome; Hideyuki Yoshitomi; Katsunori Furukawa; Satoshi Nozawa
Journal:  Surgery       Date:  2007-03-23       Impact factor: 3.982

4.  The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Neal Bhutiani; Charles R Scoggins; Kelly M McMasters; Cecilia G Ethun; George A Poultsides; Timothy M Pawlik; Sharon M Weber; Carl R Schmidt; Ryan C Fields; Kamran Idrees; Ioannis Hatzaras; Perry Shen; Shishir K Maithel; Robert C G Martin
Journal:  Surgery       Date:  2018-01-03       Impact factor: 3.982

5.  Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience.

Authors:  Min Soo Cho; Sung Hoon Kim; Seung Woo Park; Jin Hong Lim; Gi Hong Choi; Joon Seong Park; Jae Bock Chung; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-14       Impact factor: 3.452

6.  Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution.

Authors:  Alfred Wei-Chieh Kow; Choi Dong Wook; Sun Choon Song; Woo Seok Kim; Min Jung Kim; Hyo Jun Park; Jin Soek Heo; Seong Ho Choi
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

7.  Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute.

Authors:  Atsushi Nanashima; Syuuichi Tobinaga; Takafumi Abo; Ryusuke Machino; Hiroaki Takeshita; Takashi Nonaka; Shigekazu Hidaka; Kenji Tanaka; Masaki Kunizaki; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu
Journal:  Hepatogastroenterology       Date:  2012 Mar-Apr

8.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications.

Authors:  Suguru Hasegawa; Iwao Ikai; Hideaki Fujii; Etsuro Hatano; Yasuyuki Shimahara
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  2 in total

Review 1.  Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma.

Authors:  D Brock Hewitt; Zachary J Brown; Timothy M Pawlik
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

2.  Intraductal tubulopapillary neoplasms of the pancreas and biliary tract: The black swan of hepatobiliary surgery.

Authors:  Jilyan Decker; Amanda Cavanaugh; Megan Brown; Saverio Ligato; Oscar Kenneth Serrano
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.